No Data
No Data
Genenta Science Announces Amendment to Pact With AGC Biologics
Genenta Science Has Amended Its Partnership With AGC Biologics And Introduced An Exclusive GMP Suite At The AGC Biologics Cell And Gene Center Of Excellence In Milan To Manufacture Genenta's Cell Therapy Product
Genenta Science Updates ATM Sales Agreement With New Agent
Genenta Science | 6-K: Report of foreign private issuer (related to financial reporting)
Genenta Science S.p.A.'s (NASDAQ:GNTA) Market Cap Rose US$46m Last Week; Individual Investors Who Hold 55% Profited and so Did Insiders
12 Health Care Stocks Moving In Thursday's Intraday Session
No Data